Sources include whole grains, vegetables, wheat bran, and nuts
[1] [5] Research into transdermal delivery of peptide medications faces significant challenges due to the large molecular size of GLP-1 analogs and the skin's natural barrier function
In Eli Lilly's pivotal Phase 3 ATTAIN clinical trialsthe studies that led to FDA approvalparticipants taking orforglipron achieved average body weight reductions of approximately 7.9% to 8.7% over 36 to 40 weeks, depending on the dosing
Potential benefits of combining intermittent fasting and GLP-1 medications Pairing intermittent fasting with GLP-1 medications may offer several synergistic benefits: Enhanced weight loss: Both approaches reduce appetite and calorie intake, potentially leading to faster and more sustainable weight loss
GLP-1 medications can cause gastrointestinal side effects including nausea, constipation, and reduced fluid intake simply because you are eating and drinking less
First dose timing: Wait one week after last Wegovy injection